$8.87
-0.08-0.89%
Last update: Nov 12, 4:58 PM
OptimizeRx Corp
OPRXNASDAQ
OptimizeRx fell 45.1% from $16.15 to $8.87, behind the S&P 500's +10.8%. Its worst day was May 13 (−22.5%), and its low came Jun 23 at $4.54.
Nov 12, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
OptimizeRx shares fell 11.1%, while the S&P 500 fell 1.5%.
−11.1% · S&P 500 −1.5%
EPS of $0.51 beat the $0.18 estimate on $32.2M revenue (est. $31.2M); FY revenue guidance of $109.0M–$114.0M against the $122.1M consensus.
Story events cover the past 12 months · Times ET
−10.5% · S&P 500 −1.3%
EPS of $0.14 beat the $-0.02 estimate on $19.8M revenue (est. $18.4M); FY revenue guidance of $95.0M–$100.0M against the $111.6M consensus.
−22.5%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 +0.6%
OptimizeRx closed at its lowest level of the year, 71.9% below where the year started.
−3.0% · S&P 500 −1.5%
EPS of $0.16 beat the $0.09 estimate on $20.5M revenue (est. $20.3M); FY revenue guidance of $95.0M–$100.0M against the $97.5M consensus.
+24.7%, the year's best day · S&P 500 +0.7%
EPS of $0.20 beat the $0.14 estimate on $21.6M revenue (est. $21.2M); FY revenue guidance of $87.0M–$93.0M against the $96.2M consensus.
−0.9% · S&P 500 −0.4%
Where it ended: a close of $8.87 on Nov 12, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $0.39, revenue est. $34.6M).
Nothing in the past 12 months.
All OPRX dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OPRX and SPY from Benzinga historical bars. Not investment advice.
